PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $260,736 | -1.8% | 6,507 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $265,551 | -80.9% | 6,507 | -81.9% | 0.01% | -81.5% |
| Q4 2022 | $1,390,617 | -21.3% | 36,017 | +8.4% | 0.03% | -22.9% |
| Q3 2022 | $1,768,000 | +2.0% | 33,213 | +11.8% | 0.04% | +9.4% |
| Q2 2022 | $1,733,000 | -22.9% | 29,712 | +1.0% | 0.03% | -5.9% |
| Q1 2022 | $2,247,000 | +38.7% | 29,421 | +9.3% | 0.03% | +61.9% |
| Q4 2021 | $1,620,000 | +7.4% | 26,921 | 0.0% | 0.02% | +5.0% |
| Q3 2021 | $1,508,000 | +254.8% | 26,921 | +284.4% | 0.02% | +300.0% |
| Q2 2021 | $425,000 | -13.4% | 7,003 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $491,000 | -4.7% | 7,003 | -18.6% | 0.01% | 0.0% |
| Q4 2020 | $515,000 | -52.0% | 8,603 | -51.7% | 0.01% | -53.8% |
| Q3 2020 | $1,072,000 | -25.0% | 17,817 | -34.5% | 0.01% | -23.5% |
| Q2 2020 | $1,429,000 | +56.5% | 27,222 | 0.0% | 0.02% | +41.7% |
| Q1 2020 | $913,000 | -19.3% | 27,222 | -8.4% | 0.01% | 0.0% |
| Q1 2019 | $1,132,000 | -13.0% | 29,721 | -1.6% | 0.01% | -29.4% |
| Q4 2018 | $1,301,000 | +534.6% | 30,219 | +1213.9% | 0.02% | +240.0% |
| Q1 2015 | $205,000 | -3.8% | 2,300 | -4.2% | 0.01% | -16.7% |
| Q4 2014 | $213,000 | -73.2% | 2,402 | -70.7% | 0.01% | -76.0% |
| Q3 2014 | $796,000 | – | 8,204 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |